Nancy Mitchell-Sweeney

Nancy Mitchell-Sweeney is a seasoned professional in clinical operations with extensive experience in the biopharmaceutical industry. Currently serving as VP and Head of Clinical Operations at Vigil Neuroscience since September 2022, Nancy has previously held significant roles at Praxis Precision Medicines, Inc., Biogen, Sanofi Genzyme, PRA Health Sciences, Execupharm, and IQVIA, where various positions included Senior Director and Associate Director. Nancy's expertise encompasses management of clinical programs in psychiatry, movement disorders, and rare diseases, with a strong background in overseeing multiple projects and project leaders across various therapeutic areas. Additionally, Nancy began a career in clinical practice as a Crisis Clinician in psychiatry at New Britain General Hospital, enhancing a robust foundation in both clinical and operational domains.